Autres langues GSK plc

Actions

GSK

GB00BN7SWP63

Produits pharmaceutiques

Marché Fermé - London S.E. 17:35:22 14/09/2026			Varia. 5j.	Varia. 1 janv.
1 854,50 ^GBX	+4,74%		+0,43%	+1,64%

14/09	Les bourses européennes reculent face aux appels à ralentir l'IA et aux craintes inflationnistes	RE
14/09	Les valeurs défensives soutiennent le FTSE 100 à l'entame d'une semaine charnière pour les banques centrales	RE

Autres langues

14/09	Acciones europeas caen por llamados a desacelerar la IA y preocupaciones sobre la inflación
14/09	European shares slip on AI slowdown calls and inflation concerns
14/09	Defensive stocks lift FTSE 100 at start of pivotal week for central banks
14/09	Schwächer - KI-Sorgen belasten Technologie-Werte
14/09	FTSE 100 outperforms as AI worry hits Wall Street
14/09	UK Shares Rise Ahead of BoE Rate Decision; GSK Gains on Lung Cancer Data
14/09	European Stocks Close Mixed in Monday Trading; ECB Rates Could Rise as Energy Costs Fuel Inflation
14/09	European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading
14/09	GSK Plc Presents Positive Registrational Data To Potentially Expand Jideytro (Zidesamtinib) To First-Line ROS1-Positive Non-Small Cell Lung Cancer
14/09	GSK announces positive data from two clinical trials
14/09	Leichter - KI-Sicherheitsthematik bewegt Kurse
14/09	GSK PLC Announces Positive Phase III Overall Survival Data For Ris-Rez In Relapsed Small Cell Lung Cancer In China
14/09	UK's FTSE 100 rises as oil stocks gain; key announcements in focus
14/09	European shares slip as AI slowdown call hits tech, oil surge weighs
14/09	WINNERS & LOSERS: GlobalData sinks; Sage rises on AI safety fear
14/09	GSK plans expanded US submission for Jideytro after positive results
14/09	Leichter - "KI-Aktien" sehr schwach - Roche mit Studienerfolg fest
14/09	GSK's Potential Small-Cell Lung Cancer Drug Meets Primary Endpoint in Late-Stage Trial
14/09	GSK Reports 94% Response Rate for Lung Cancer Drug Trial
14/09	GSK's Relapsed Small Cell Lung Cancer Therapy Meets Primary Endpoint in Late-stage Study
14/09	Morning Meeting: Die KI-Liebe der Märkte bekommt erste Risse
14/09	GSK Reports Positive Data from Registrational Trial of Non-small Cell Lung Cancer Drug Jideytro
14/09	DSM-Firmenich geht Partnerschaft mit KI-Start-up Boltz ein
14/09	MORNING BRIEFING - Deutschland/Europa -2-
14/09	GSK mit Studienerfolg bei Lungenkrebs-Medikament